Cargando…
PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro
BACKGROUND: The effects of bone marrow mesenchymal stem cells (BMSCs) during the treatment of cartilage damage have been proven to be attributed to paracrine mechanisms, particularly the effect of exosomes. Exosomes from different batches are inhomogeneous, and different treatment effects are observ...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052609/ https://www.ncbi.nlm.nih.gov/pubmed/35488245 http://dx.doi.org/10.1186/s13075-022-02778-x |
_version_ | 1784696818802622464 |
---|---|
author | Shao, Li-tao Luo, Liang Qiu, Jie-hong Deng, David Y. B. |
author_facet | Shao, Li-tao Luo, Liang Qiu, Jie-hong Deng, David Y. B. |
author_sort | Shao, Li-tao |
collection | PubMed |
description | BACKGROUND: The effects of bone marrow mesenchymal stem cells (BMSCs) during the treatment of cartilage damage have been proven to be attributed to paracrine mechanisms, particularly the effect of exosomes. Exosomes from different batches are inhomogeneous, and different treatment effects are observed between samples. The purpose of this research was to find more effective and homogeneous exosomes for the repair of chondrocytes in osteoarthritis (OA). We observed the potential effects and possible mechanisms of exosomes derived from parathyroid hormone (PTH) (1-34)-preconditioned BMSCs (Exo(PTH)) in the alleviation of OA. MATERIALS AND METHODS: Exosomes derived from BMSCs (Exo(BMSC)) and Exo(PTH) were isolated by differential centrifugation. Primary rat chondrocytes were used to establish the OA model by interleukin 1 beta (IL-1β) in vitro. The effects of these two types of exosomes on OA chondrocyte proliferation, migration, apoptosis, and extracellular matrix formation were measured and compared. We observed changes in IL-2, TNF-α, and IL-6 levels via Western blotting (WB), and quantitative real-time PCR (qRT–PCR). RESULTS: We successfully extracted Exo(BMSC) and Exo(PTH) and established an IL-1β-induced OA model in primary chondrocytes from rats. Our study showed that IL-2, TNF-α, and IL-6 levels increased significantly in OA chondrocytes; however, both Exo(BMSC) and Exo(PTH) reduced the levels of IL-2, TNF-α, and IL-6. In addition, Exo(PTH) exhibited stronger anti-inflammatory effects. Exo(PTH) had a more marked effect on proliferation, migration, and production of the extracellular matrix (Col-II) in OA chondrocytes than Exo(BMSC) at 24 h. CONCLUSION: Exo(PTH) increased the migration, proliferation, and chondral matrix formation of OA chondrocytes in vitro. In OA chondrocyte therapy, the potential mechanism of Exo(PTH) might involve the inhibition of production of proinflammatory cytokines. Although the two types of exosomes had some similar effects, most effects of Exo(PTH) were better than those of Exo(BMSC), so Exo(PTH) may have a better ability to alleviate OA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-022-02778-x. |
format | Online Article Text |
id | pubmed-9052609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90526092022-04-30 PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro Shao, Li-tao Luo, Liang Qiu, Jie-hong Deng, David Y. B. Arthritis Res Ther Research BACKGROUND: The effects of bone marrow mesenchymal stem cells (BMSCs) during the treatment of cartilage damage have been proven to be attributed to paracrine mechanisms, particularly the effect of exosomes. Exosomes from different batches are inhomogeneous, and different treatment effects are observed between samples. The purpose of this research was to find more effective and homogeneous exosomes for the repair of chondrocytes in osteoarthritis (OA). We observed the potential effects and possible mechanisms of exosomes derived from parathyroid hormone (PTH) (1-34)-preconditioned BMSCs (Exo(PTH)) in the alleviation of OA. MATERIALS AND METHODS: Exosomes derived from BMSCs (Exo(BMSC)) and Exo(PTH) were isolated by differential centrifugation. Primary rat chondrocytes were used to establish the OA model by interleukin 1 beta (IL-1β) in vitro. The effects of these two types of exosomes on OA chondrocyte proliferation, migration, apoptosis, and extracellular matrix formation were measured and compared. We observed changes in IL-2, TNF-α, and IL-6 levels via Western blotting (WB), and quantitative real-time PCR (qRT–PCR). RESULTS: We successfully extracted Exo(BMSC) and Exo(PTH) and established an IL-1β-induced OA model in primary chondrocytes from rats. Our study showed that IL-2, TNF-α, and IL-6 levels increased significantly in OA chondrocytes; however, both Exo(BMSC) and Exo(PTH) reduced the levels of IL-2, TNF-α, and IL-6. In addition, Exo(PTH) exhibited stronger anti-inflammatory effects. Exo(PTH) had a more marked effect on proliferation, migration, and production of the extracellular matrix (Col-II) in OA chondrocytes than Exo(BMSC) at 24 h. CONCLUSION: Exo(PTH) increased the migration, proliferation, and chondral matrix formation of OA chondrocytes in vitro. In OA chondrocyte therapy, the potential mechanism of Exo(PTH) might involve the inhibition of production of proinflammatory cytokines. Although the two types of exosomes had some similar effects, most effects of Exo(PTH) were better than those of Exo(BMSC), so Exo(PTH) may have a better ability to alleviate OA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-022-02778-x. BioMed Central 2022-04-29 2022 /pmc/articles/PMC9052609/ /pubmed/35488245 http://dx.doi.org/10.1186/s13075-022-02778-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Shao, Li-tao Luo, Liang Qiu, Jie-hong Deng, David Y. B. PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro |
title | PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro |
title_full | PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro |
title_fullStr | PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro |
title_full_unstemmed | PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro |
title_short | PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro |
title_sort | pth (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on oa chondrocyte repair in vitro |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052609/ https://www.ncbi.nlm.nih.gov/pubmed/35488245 http://dx.doi.org/10.1186/s13075-022-02778-x |
work_keys_str_mv | AT shaolitao pth134enhancesthetherapeuticeffectofbonemarrowmesenchymalstemcellderivedexosomesbyinhibitingproinflammatorycytokinesexpressiononoachondrocyterepairinvitro AT luoliang pth134enhancesthetherapeuticeffectofbonemarrowmesenchymalstemcellderivedexosomesbyinhibitingproinflammatorycytokinesexpressiononoachondrocyterepairinvitro AT qiujiehong pth134enhancesthetherapeuticeffectofbonemarrowmesenchymalstemcellderivedexosomesbyinhibitingproinflammatorycytokinesexpressiononoachondrocyterepairinvitro AT dengdavidyb pth134enhancesthetherapeuticeffectofbonemarrowmesenchymalstemcellderivedexosomesbyinhibitingproinflammatorycytokinesexpressiononoachondrocyterepairinvitro |